The Discovery of Phenylketonuria: The Story of a Young Couple, Two Retarded Children, and a Scientist

  title={The Discovery of Phenylketonuria: The Story of a Young Couple, Two Retarded Children, and a Scientist},
  author={Siegried A. Centerwall and Willard R. Centerwall},
  pages={103 - 89}
In the 1920s, a little girl 3 years of age was brought from China to the United States by her American mother. [] Key Method In the United States, she also went from doctors to psychologists to clinics looking for someone who could help. Finally, she went to the Mayo Clinic in Rochester, Minnesota. When she had answered all of the doctor's questions, and all the tests were finished, they still could not tell her what was wrong. There was nothing they could do. The disease from which the little girl suffered…
The Early History of PKU
In the short review below, the authors give a partly personal and therefore rare account of the early history of PKU, its treatment and the start of neonatal screening.
How individuals with phenylketonuria experience their illness: an age-related qualitative study.
The results suggested the age-related PKU experience is a paradox, either to feel normal but isolated from the social context, or to be different while participating in the convivial aspects of the social being, and the need for education about the disease tailored to the individual and growing needs.
Clinical and demographic aspects of phenylketonuria in Bahia State, Brazil
The results showed elevated age at the beginning of the treatment, which may compromise the program results and require careful investigation of families searching for individuals with mental retardation of unknown etiology that would benefit from the treatment.
Ivar Asbjörn Følling
This study reported a laboratory test to confirm this metabolic disease, which was later determined to be an autosomal recessive metabolic disorder, and determined that diet modification would drastically improve the outcome and prevent the onset of mental retardation.
Asbjørn Følling and the Discovery of Phenylketonuria
  • S. Christ
  • Medicine
    Journal of the history of the neurosciences
  • 2003
The story of Følling's discovery of phenylketonuria and his subsequent contributions to the area of study are focused on.
Treatment options and dietary supplements for patients with phenylketonuria
A definition of PKU is presented and the evolution of the management practices since the first treated child by Dr. Bickel, in the early 1950s, and the differences between early and late diagnosed patients are highlighted, mainly in terms of the ‘Two Worlds ofPKU’.
Article Commentary: The contributions of Louis I Woolf to the treatment, early diagnosis and understanding of phenylketonuria
The history of this treatment, Woolf's role in the establishment of neonatal PKU screening and his other contributions to the authors' understanding of this condition are described.
Outpatient General Anesthesia of a Patient with Phenylketonuria - A case report -
A successful anesthetic management in a patient with phenylketonuria for dental procedures is reported, and patients have an increased risk of developing vitamin B12 deficiency because of a limited intake of animal products.


Effect of a phenylalanine-restricted diet on patients with phenylketonuria; clinical observations in three cases.
The major biochemical abnormalities in all the patients studied were found to disappear when the high blood levels of phenylalanine, which are characteristic of the disorder, were reduced to the normal range by the dietary regimen.
Rapid diagnosis of MCAD deficiency: quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry.
A robust and accurate semiautomated method for the analysis of medium chain length acylcarnitines as their butyl esters was developed and validated and a validated method now exists for prospective newborn screening for MCAD deficiency.
Fluorimetric method for the determination of phenylalanine in serum
Abstract The fluorimetric determination of phenylalanine is based on the enhancement of the fluorescence of a phenylalanine-ninhydrin reaction product by a peptide, leucylalaninc. The method allows
The Child Who Never Grew
Molecular basis of phenylketonuria and related hyperphenylalaninemias: Mutations and polymorphisms in the human phenylalanine hydroxylase gene
Mutations in the human phenylalanine hydroxylase gene producing phenylketonuria or hyperphenylalaninemia have now been identified in many patients from various ethnic groups, and a significant correlation has been observed between residual PAH activity and disease phenotype.
Phenylketonuria (FOLLING's disease). The story of its discovery.
Studies on phenylpyruvic oligophrenia; the position of the metabolic error.
  • G. Jervis
  • Biology, Medicine
    The Journal of biological chemistry
  • 1947